Laboratorios LETI SL:企業の戦略的SWOT分析

◆英語タイトル:Laboratorios LETI SL - Strategic SWOT Analysis Review
◆商品コード:DATA904C15909
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Laboratorios LETI SL – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Laboratorios LETI SL (LETI) is biopharmaceutical research company that offers products for early diagnosis, disease prevention and specialized body care. The company’s products include allergen extracts for the diagnosis and treatment of allergy; dermopharmaceutical products and other specialty products for personal care; and solutions for the prevention, diagnosis and treatment of primary immune diseases of companion animals, including allergy and leishmaniasis. It has production facility and allergy research laboratory in Tres Cantos, Spain. The company operates through its subsidiaries in Germany and Portugal; and a network of distributors across Europe, Latin America and Africa. LETI is headquartered in Barcelona, Spain.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Laboratorios LETI SL – Key Facts
Laboratorios LETI SL – Key Employees
Laboratorios LETI SL – Major Products and Services
Laboratorios LETI SL – History
Laboratorios LETI SL – Company Statement
Laboratorios LETI SL – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Laboratorios LETI SL – Business Description
Laboratorios LETI SL – SWOT Analysis
SWOT Analysis – Overview
Laboratorios LETI SL – Strengths
Laboratorios LETI SL – Weaknesses
Laboratorios LETI SL – Opportunities
Laboratorios LETI SL – Threats
Laboratorios LETI SL – Key Competitors
Section 3 – Company’s, Lifesciences Financial Deals and Alliances
Laboratorios LETI SL, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Laboratorios LETI SL, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Laboratorios LETI SL, Recent Deals Summary
Section 4 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Laboratorios LETI SL, Key Facts
Laboratorios LETI SL, Key Employees
Laboratorios LETI SL, Major Products and Services
Laboratorios LETI SL, History
Laboratorios LETI SL, Other Locations
Laboratorios LETI SL, Subsidiaries
Laboratorios LETI SL, Key Competitors
Laboratorios LETI SL, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Laboratorios LETI SL, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Laboratorios LETI SL, Recent Deals Summary

List of Figures
Laboratorios LETI SL, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Laboratorios LETI SL, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Laboratorios LETI SL:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sparkletts:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Sparkletts Mergers and Acquisit …
  • Interpump Group S.p.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Interpump Group S.p.A. Mergers …
  • HistoRx, Inc.:(医療機器分野)企業M&A及び提携動向
    Summary HistoRx, Inc. (HistoRx) is a biopharmaceutical company. The company provides pharmaceutical and research services. Its AQUA technology is used to develop a line of multi-marker tissue-based cancer diagnostics which is help precise measurement of critical, localized proteins. The technology o …
  • Finox AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Finox AG (Finox), a subsidiary of Richter Gedeon Nyrt, is a drug development and manufacturing company that offers fertility treatment products. The company develops drugs in the field of fertility therapies. Its product portfolio includes biosimilars and patient friendly delivery devices. F …
  • Intershop Communications AG (ISH2):企業の財務・戦略的SWOT分析
    Summary Intershop Communications AG (Intershop), formerly NetConsult GmbH, is an information technology company that develops and offers integrated e-commerce solutions. The company provides services such as omni-channel management, experience management, product information management, marketing an …
  • Berjaya Land Bhdの企業概要及び財務/SWOT分析
    Berjaya Land Bhd Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly fore …
  • Infovide-Matrix S.A. (IMX):企業概要、財務及び戦略的SWOT分析
    Summary Infovide-Matrix S.A. (Infovide-Matrix) is an information technology service provider. The company offers consulting services and information technology solutions. Its consulting services include business consulting, architectural and technological consulting, and managerial consulting. Infov …
  • Sigma-Tau Pharmaceuticals, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Sigma-Tau Pharmaceuticals, Inc. …
  • Immunocore Limited(製薬・医療分野):企業M&A動向
    Summary Immunocore limited (Immunocore) is a biotechnology company. The company develops biological therapeutics for the treatment of cancer and a range of other serious diseases. It develops ImmTAC reagents for a number of molecular targets applicable to the treatment of a range of clinical indicat …
  • United Microelectronics Corporation:企業のM&A・提携・投資分析
    United Microelectronics Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's United Microelectronics Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on …
  • Dassault Systemes SA:企業の戦略・SWOT・財務分析
    SummaryDassault Systemes SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Fi …
  • PharmaEssentia Corp (6446)-製薬・医療分野:企業M&A・提携分析
    Summary PharmaEssentia Corp (PharmaEssentia) is a research and development company that develops therapeutic products for the treatment of human diseases. The company’s pipeline product include P1101, a new generation PEG-Interferon-alpha-2b which is developed using PEGylation technology platform. I …
  • AlphaVax, Inc.:製品開発パイプライン動向2015
    AlphaVax, Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘AlphaVax, Inc. - Product Pipeline Review - 2015’, provides an overview of the AlphaVax, Inc.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic de …
  • Ariad Pharmaceuticals Inc (ARIA):企業のM&A・提携動向(医療分野)
    Summary Ariad Pharmaceuticals Inc (Ariad) focuses on the discovery, development and marketing of small-molecule oncology therapies. Its products are indicated to treat chronic and acute leukemia, lung cancer and other difficult to treat cancers. The company’s lead product, Iclusig (ponatinib) is ind …
  • Applied Genetic Technologies Corp (AGTC):医療機器:M&Aディール及び事業提携情報
    Summary Applied Genetic Technologies Corp (AGTC) is a pharmaceutical company that provides development of eye disease cures. The company develops treatments for patients that have diseases caused by broken genes. It offers products such as x-linked retinoschisis, achromatopsia, x-linked retinitis pi …
  • Brii Biosciences:製薬・医療:M&Aディール及び事業提携情報
    Summary Brii Biosciences is an independent biotechnology company that focuses on developing and commercializing innovative medicines for infectious diseases, liver and lung diseases, and other chronic diseases. The company strives to advance breakthroughs in science and technology, and enable patien …
  • Belvedere S.A.:企業概要・SWOT・財務分析
    Summary Canadean's "Belvedere S.A. : Consumer Packaged Goods - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business descripti …
  • EMS Energy Limited (42O):企業のM&A・提携動向(石油・ガス分野)
    Summary EMS Energy Limited (EMS Energy) is an energy services company that designs, manufactures and installs engineering solutions and products. The company offers products such as deck machineries, drilling and well intervention systems, offshore cranes, and other mechanical load handling systems. …
  • HCA Holdings, Inc.:企業のM&A・提携・投資分析
    HCA Holdings, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HCA Holdings, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Oncolys BioPharma Inc.(製薬・医療分野):企業M&A動向
    Summary Oncolys BioPharma Inc. (Oncolys) is a biotechnology company. The company discovers, develops and partners targeted treatments for cancer and infectious diseases. Its products include telomelysin: OBP-301, OBP-801, HDAC-I, OBP-601, OBP-AI 1, OBP-AI 2 and telomescan: OBP-401. Oncolys operates …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆